Ciel Medical is a biotechnology company based in Redwood City, California, specializing in innovative medical solutions for critical care and kidney stone treatment. Since its inception in 2012, the company has been dedicated to revolutionizing healthcare through advanced biotechnology. Their focus lies in the development of medical devices to combat ventilator-associated pneumonia, enhance kidney stone treatments, and improve patient protection in intensive care units. Ciel Medical's commitment to innovation has attracted significant investment, with a $325.00K Series A investment from Sood Ventures and Astia Angels in May 26, 2015. This promising startup is positioned at the forefront of the biotechnology, health care, medical devices, and pharmaceutical industries, holding great potential for growth and impact within the healthcare sector.
No recent news or press coverage available for Ciel Medical.